CAS 1312691-33-0

Mivavotinib

Produit contrôlé

CAS : 1312691-33-0

Formule : C₁₇H₂₁FN₆O

Couleur et forme : Neat

Masse moléculaire : 344.387

Ref: TR-M385035

Mivavotinib

CAS : 1312691-33-0

Mivavotinib is a potent inhibitor of the Src family tyrosine kinase Shp2. It has been shown to be effective in treating cancer patients with malignant tumors or who are at high risk of developing a tumor. Mivavotinib has also been shown to have beneficial effects in patients with autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. The drug works by binding to the SHP2 protein, which prevents it from associating with other proteins and blocks its activity. This inhibition leads to the prevention of cell proliferation and the promotion of cancer cell death. The structural formula for mivavotinib is shown below:

Formule : C₁₇H₂₁FN₆O

Degré de pureté : Min. 95%

Masse moléculaire : 344.4 g/mol

Ref: 3D-MCC69133

TAK-659

CAS : 1312691-33-0

TAK-659 is a spleen tyrosine kinase (SYK) inhibitor.

Formule : C₁₇H₂₁FN₆O

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 344.39

Ref: TM-T21062